Study of Genotype and Phenotype in Patients With Alpha 1-Antitrypsin Deficiency
2 other identifiers
observational
160
1 country
1
Brief Summary
OBJECTIVES: I. Establish cell lines from patients with alpha 1-antitrypsin deficiency in order to examine genetic traits that predispose to liver injury.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 1, 1999
CompletedFirst Submitted
Initial submission to the registry
April 6, 2000
CompletedFirst Posted
Study publicly available on registry
April 7, 2000
CompletedJune 24, 2005
May 1, 2002
April 6, 2000
June 23, 2005
Conditions
Keywords
Eligibility Criteria
Contact the study team to discuss eligibility requirements. They can help determine if this study is right for you.
Sponsors & Collaborators
Study Sites (1)
Children's Hospital of Pittsburgh
Pittsburgh, Pennsylvania, 15213, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
David H. Perlmutter
University of Pittsburgh
Study Design
- Study Type
- observational
- Sponsor Type
- NIH
Study Record Dates
First Submitted
April 6, 2000
First Posted
April 7, 2000
Study Start
March 1, 1999
Last Updated
June 24, 2005
Record last verified: 2002-05